| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,847,000 | 1,471,000 | 1,677,000 | 1,968,000 | | Cost of Revenue | 1,354,000 | 1,265,000 | 1,395,000 | 1,791,000 | | | Gross Profit | 493,000 | 206,000 | 282,000 | 177,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 92,000 | 22,000 | 31,000 | 62,000 | | Non Recurring |
-
|
-
|
-
| 50,000 | | Others | (9,000) | 9,000 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 410,000 | 175,000 | 251,000 | 65,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (9,000) | (32,000) | (1,000) | (252,000) | | Earnings Before Interest And Taxes | 422,000 | 149,000 | 250,000 | 115,000 | | Interest Expense | 198,000 | 207,000 | 210,000 | 234,000 | | Income Before Tax | 224,000 | (58,000) | 40,000 | (119,000) | | Income Tax Expense | (7,000) | 15,000 | 9,000 | 13,000 | | Minority Interest | 3,000 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 240,000 | (79,000) | 31,000 | (434,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 23,000 | | Extraordinary Items |
-
|
-
|
-
| 302,000 | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 240,000 | (79,000) | 31,000 | (109,000) | | Preferred Stock And Other Adjustments | (2,000) | 1,000 | 1,000 |
-
| | | Net Income Applicable To Common Shares | $238,000 | ($78,000) | $32,000 | ($109,000) |
|
0.29% Nasdaq 
0.11%
Income Statement
